Clinical Trial Update: Pharmocokinetic/Pharmacodynamic (PK/PD) Study of the Combination Cetuximab/Gefitinib [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic/pharmacodynamic study evaluating the combination of cetuximab and gefitinib in colorectal cancer, head and neck cancer, and non-small ce…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Head and Neck Cancer
• Non-small Cell Lung Cancer

Drugs mentioned

• ERBITUX (cetuximab)
• Iressa (gefitinib)

Snippet

Sponsor: Harrison Clinical Research | Conditions: Colorectal Cancer, Head and Neck Cancer | Phase 1 | Status: COMPLETED